BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,168,000 | +26.8% | 17,737 | -2.7% | 0.00% | +100.0% |
| Q2 2022 | $921,000 | -27.5% | 18,233 | -8.3% | 0.00% | -50.0% |
| Q1 2022 | $1,270,000 | -41.0% | 19,890 | -1.0% | 0.00% | -33.3% |
| Q4 2021 | $2,151,000 | +1.4% | 20,088 | -2.7% | 0.00% | 0.0% |
| Q3 2021 | $2,122,000 | +634.3% | 20,639 | +527.1% | 0.00% | – |
| Q2 2021 | $289,000 | +21.4% | 3,291 | +34.3% | 0.00% | – |
| Q1 2021 | $238,000 | -13.8% | 2,450 | -0.5% | 0.00% | – |
| Q4 2020 | $276,000 | -8.3% | 2,462 | -24.2% | 0.00% | -100.0% |
| Q3 2020 | $301,000 | +2.7% | 3,250 | -13.4% | 0.00% | 0.0% |
| Q2 2020 | $293,000 | +6.5% | 3,751 | +9.5% | 0.00% | 0.0% |
| Q4 2019 | $275,000 | -72.0% | 3,425 | -67.1% | 0.00% | -66.7% |
| Q2 2019 | $983,000 | – | 10,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |